Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.

about

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.

P2860

Q37496863-CD2A40D1-A28B-4CBF-8527-8192BCA0E951 Q38764240-D550290A-8175-4673-AF43-F6D2E6720B18

P2860

Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.

Item

http://www.wikidata.org/entity/Q48579677

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@en

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@nl

type

Item

label

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@en

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@nl

prefLabel

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@en

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI.

@nl

P1476

Assessment of Progression-Free ...... Dynamic Contrast-Enhanced MRI

@en

P2093

F F Bajrovic

http://www.w3.org/2001/XMLSchema#string

K Surlan-Popovic

http://www.w3.org/2001/XMLSchema#string

U Smrdel

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Normalization of the vasculature for treatment of cancer and other diseases.

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.

Key factors in the acquisition of contrast kinetic data for oncology.

Classic models for dynamic contrast-enhanced MRI.

A review of the automated detection of change in serial imaging studies of the brain.

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

P2888

s00062-014-0328-0

P304

39-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00062-014-0328-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sotirios Bisdas

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25164691

http://www.w3.org/2001/XMLSchema#string

Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.

about

P2860

P2860

Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698